Abstract
AbstractCommunity perception of the safety of vaccines in the interest of public health influences vaccine uptake. Challenges for active vaccine safety monitoring include survey response rates, unbiased reporting and the balance between specificity and sensitivity of signal detection methods. To address these problems, we used causal DAGs and statistical methods to guide understanding of biological and behavioural factors which may influence vaccine safety signal detection. The DAGs informed the generation of scenarios in which these factors were varied. A posterior predictive analysis (PPA) signal detection method, based upon a Bayesian logistic model, was used to detect signals across the scenarios. In the high probability of severe reaction scenarios, true signals were generated where there was higher survey participation with more survey responder AEFI data available for analysis. In the low probability of severe reaction scenarios, false signals were generated when there was a strong influence of reaction severity on survey participation and reports of severe reactions. Low rates of survey participation reduce the amount of data available to inform the parameters of the statistical model, and therefore reduce the certainty regarding the value of these parameters. We obtained insights into the value of the causal DAG to account for survey non-response, to guide understanding of short-term vaccine safety, interpret the results of the PPA analysis under plausible scenarios, and review implications for future vaccine safety monitoring
Publisher
Cold Spring Harbor Laboratory
Reference23 articles.
1. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine
2. The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children
3. Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States
4. Organization WH . Causality assessment of an adverse event following immunization (AEFI): user manual for the revised who classification. World Health Organization; 2019.
5. Food U , Administration D . Guidance for industry: toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. Food and Drug Administration: Silver Spring, MD, USA. 2007.